A world-leading international trial into the immune boosting benefits of the tuberculosis vaccine, BCG, has found it does not protect health care workers against COVID-19. The BRACE trial, led by ...

The tuberculosis vaccine (or BCG vaccine) does not protect elderly with co-morbidities against disease symptoms caused by a coronavirus infection. This was reported in the BCG-PRIME study which was ...

Administering the Bacillus Calmette-Guérin (BCG) vaccine during the active phase of COVID-19 may help protect against the development of long COVID. A phase 3 clinical trial initiated in early 2020 ...

A world-leading international trial into the immune boosting benefits of the tuberculosis vaccine, BCG, has found it does not protect healthcare workers against COVID-19. The BRACE trial, led by ...

In a recent study in The New England Journal of Medicine, researchers performed a randomized controlled trial (RCT) to investigate whether Bacille Calmette-Guérin (BCG) vaccines could lower ...

The bacillus Calmette-Guérin (BCG) vaccine failed to protect against COVID-19 and other respiratory tract infections (RTIs) among older adults with comorbidities, according to a randomized trial from ...

Early in the pandemic, scientists began testing an old TB vaccine against the coronavirus. But the trial enrolled fewer participants than expected as new Covid vaccines were introduced, and no ...

CAPE TOWN (Reuters) - The idea of testing the BCG vaccine in Africa against COVID-19 was bound to cause controversy, yet officials say efforts underway could, if successful, give the continent a cheap ...